History of Executive Privilege, and More from CRS
A 2008 report by the Congressional Research Service discussed the history of claims of executive privilege, including various unresolved questions surrounding its use. The Obama Administration asserted executive privilege today in connection with records sought by a House Committee. See Presidential Claims of Executive Privilege: History, Law, Practice and Recent Developments, updated August 21, 2008.
Newly updated reports from the Congressional Research Service that Congress has not made publicly available include the following.
U.S.-China Military Contacts: Issues for Congress, June 19, 2012
Free Trade Agreements: Impact on U.S. Trade and Implications for U.S. Trade Policy, June 18, 2012
Madagascar’s Political Crisis, June 18, 2012
Armenia, Azerbaijan, and Georgia: Political Developments and Implications for U.S. Interests, June 15, 2012
U.S. Trade Deficit and the Impact of Changing Oil Prices, June 18, 2012
Unauthorized Alien Students: Issues and “DREAM Act” Legislation, June 19, 2012
Federal Taxation of Aliens Working in the United States, May 18, 2012
DNA synthesis and export controls remain the primary regulatory safeguards against de novo production of harmful biological agents, yet governance frameworks lack the situational awareness and enforcement capacity to keep pace with rapidly falling technical barriers.
Called today to speak on behalf of U.S. science and technology, Dr. Jedidah Isler, astrophysicist, educator, strategist, policy-maker, and science communicator, will provide constructive, nonpartisan feedback to the House Committee’s hearing “American Global Competitiveness at 250: Legislative Proposals to Secure U.S. Technology Leadership.”
“Federal data and access to it is not a partisan issue. It is a people issue. Our country cannot achieve greatness without access to the data that measure what we value, who we are, and where we’re heading.”
The United States’ biosecurity governance system is structurally incapable of detecting and responding to certain classes of threats. U.S. biosecurity tools have not kept pace with technological advancements or a changing threat landscape.